Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 72162-1544 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - lbl721621544
This is a medication description for Pregabalin capsules containing 100mg of the active ingredient. The medication should be kept out of reach of children and stored at room temperature between 20-25°C (68-77°F). The drug is packaged into 90 capsules by Bryant Ranch Prepack, Inc. and manufactured by ScieGen Pharmaceuticals Inc. The National Drug Code (NDC) for this medication is 72162-1544-9. It is only available with a prescription.*
Figure 1 - pregabalin fig01
Figure 2 - pregabalin fig02
The text provided is a table showing the percentage improvement in pain for patients who were administered Pregabalin 160 mg for three days. The table shows 100%, 2%, and 10% improvement for different time periods. The row headers are not clearly visible. The remaining part of the text is not relevant to the description.*
Figure 3 - pregabalin fig03
Figure 4 - pregabalin fig04
Figure 5 - pregabalin fig05
The text is a table showing the dosage of Fregabalin, Pregataiin, and Placebo for patients and the percent improvement in pain from baseline. The table also has a column labeled "Pacent of Patients Improved" with an unreadable set of numbers.*
Figure 6 - pregabalin fig06
Figure 7 - pregabalin fig07
Figure 9 - pregabalin fig08
Figure 10 - pregabalin fig09
This appears to be a table outlining the estimated percentage of subjects without LTR (unknown what LTR stands for) for a medication called "Progabain" and a placebo. The percentages range from 0% to 100% with intervals of 10%. The table also includes a timeline measured in days, with increments of 20 days up to 120 and then 160 and 180. It is unclear what the context or purpose of this table is.*
Figure 11 - pregabalin fig10
Figure 12 - pregabalin fig11
This appears to be a table presenting the percent improvement of subjects who took either pregabalin or a placebo from baseline to week 16. The subjects who took pregabalin seem to have a higher percent improvement compared to those who took placebo. The table also includes numerical values ranging from 100 to 280.*
Cockcroft and Gault equation - pregabalin formula
This appears to be a formula for calculating the creatinine clearance rate for a patient. The calculation involves subtracting the patient's age in years from 140, then multiplying that result by their weight in kilograms. For female patients, this number is then multiplied by 0.85. The final calculation involves multiplying 72 by the patient's serum creatinine level in milligrams per deciliter.*
Chemical Structure - pregabalin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.